These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 26683913)

  • 1. A Review of GM-CSF Therapy in Sepsis.
    Mathias B; Szpila BE; Moore FA; Efron PA; Moldawer LL
    Medicine (Baltimore); 2015 Dec; 94(50):e2044. PubMed ID: 26683913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of granulocyte-monocyte colony-stimulating factor therapy on leukocyte function and clearance of serious infection in nonneutropenic patients.
    Rosenbloom AJ; Linden PK; Dorrance A; Penkosky N; Cohen-Melamed MH; Pinsky MR
    Chest; 2005 Jun; 127(6):2139-50. PubMed ID: 15947332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Granulocyte-macrophage colony-stimulating factor to reverse sepsis-associated immunosuppression: a double-blind, randomized, placebo-controlled multicenter trial.
    Meisel C; Schefold JC; Pschowski R; Baumann T; Hetzger K; Gregor J; Weber-Carstens S; Hasper D; Keh D; Zuckermann H; Reinke P; Volk HD
    Am J Respir Crit Care Med; 2009 Oct; 180(7):640-8. PubMed ID: 19590022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Granulocyte-colony stimulating factor (G-CSF) and granulocyte-macrophage colony stimulating factor (GM-CSF) for sepsis: a meta-analysis.
    Bo L; Wang F; Zhu J; Li J; Deng X
    Crit Care; 2011; 15(1):R58. PubMed ID: 21310070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. G-CSF and GM-CSF for treating or preventing neonatal infections.
    Carr R; Modi N; Doré C
    Cochrane Database Syst Rev; 2003; 2003(3):CD003066. PubMed ID: 12917944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor levels in critical illness including sepsis and septic shock: relation to disease severity, multiple organ dysfunction, and mortality.
    Presneill JJ; Waring PM; Layton JE; Maher DW; Cebon J; Harley NS; Wilson JW; Cade JF
    Crit Care Med; 2000 Jul; 28(7):2344-54. PubMed ID: 10921563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Granulocyte-macrophage colony stimulating factor administered as prophylaxis for reduction of sepsis in extremely preterm, small for gestational age neonates (the PROGRAMS trial): a single-blind, multicentre, randomised controlled trial.
    Carr R; Brocklehurst P; Doré CJ; Modi N
    Lancet; 2009 Jan; 373(9659):226-33. PubMed ID: 19150703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myeloid colony-stimulating factors: use in the newborn.
    Sreenan C; Osiovich H
    Arch Pediatr Adolesc Med; 1999 Sep; 153(9):984-8. PubMed ID: 10482217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized phase II trial of granulocyte-macrophage colony-stimulating factor therapy in severe sepsis with respiratory dysfunction.
    Presneill JJ; Harris T; Stewart AG; Cade JF; Wilson JW
    Am J Respir Crit Care Med; 2002 Jul; 166(2):138-43. PubMed ID: 12119223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Granulocyte-monocyte colony-stimulating factor for the treatment of sepsis: a meta analysis].
    Song F; Liu YL; Yang KH; Ma L
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2011 May; 23(5):294-8. PubMed ID: 21549068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized trial of granulocyte-macrophage colony-stimulating factor in neonates with sepsis and neutropenia.
    Bilgin K; Yaramiş A; Haspolat K; Taş MA; Günbey S; Derman O
    Pediatrics; 2001 Jan; 107(1):36-41. PubMed ID: 11134431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of granulocyte-macrophage colony-stimulating factor on the immune response of circulating monocytes after severe trauma.
    Flohé S; Lendemans S; Selbach C; Waydhas C; Ackermann M; Schade FU; Kreuzfelder E
    Crit Care Med; 2003 Oct; 31(10):2462-9. PubMed ID: 14530752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized, controlled trial of prophylactic granulocyte-macrophage colony-stimulating factor in human newborns less than 32 weeks gestation.
    Carr R; Modi N; Doré CJ; El-Rifai R; Lindo D
    Pediatrics; 1999 Apr; 103(4 Pt 1):796-802. PubMed ID: 10103305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of G-CSF GM-CSF in the management of infections in preterm newborns: an update.
    Castagnola E; Dufour C
    Early Hum Dev; 2014 Sep; 90 Suppl 2():S15-7. PubMed ID: 25220119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor have differential effects on neonatal and adult neutrophil survival and function.
    Molloy EJ; O'Neill AJ; Grantham JJ; Sheridan-Pereira M; Fitzpatrick JM; Webb DW; Watson RW
    Pediatr Res; 2005 Jun; 57(6):806-12. PubMed ID: 15718363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential use of granulocyte colon-stimulating factor and granulocyte-macrophage colony-stimulating factor in neonates.
    Bracho F; Goldman S; Cairo MS
    Curr Opin Hematol; 1998 May; 5(3):215-20. PubMed ID: 9664163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemoradiotherapy with or without granulocyte-macrophage colony-stimulating factor in the treatment of limited-stage small-cell lung cancer: a prospective phase III randomized study of the Southwest Oncology Group.
    Bunn PA; Crowley J; Kelly K; Hazuka MB; Beasley K; Upchurch C; Livingston R; Weiss GR; Hicks WJ; Gandara DR
    J Clin Oncol; 1995 Jul; 13(7):1632-41. PubMed ID: 7602352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous delivery of granulocyte-macrophage colony stimulating factor impairs survival in lipopolysaccharide-induced sepsis.
    Krebs J; Hillenbrand A; Tsagogiorgas C; Patry C; Tönshoff B; Yard B; Beck G; Rafat N
    PLoS One; 2019; 14(6):e0218602. PubMed ID: 31220157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Granulopoiesis-stimulating factors to prevent adverse effects in the treatment of malignant lymphoma.
    Bohlius J; Reiser M; Schwarzer G; Engert A
    Cochrane Database Syst Rev; 2004; (3):CD003189. PubMed ID: 15266474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immunomodulation for sepsis: a change of tack?].
    Leentjens J; Kox M; Pickkers P
    Ned Tijdschr Geneeskd; 2014; 158():A6859. PubMed ID: 24518844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.